Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Deffered Revenue (2024 - 2025)

Historic Non-Current Deffered Revenue for Gossamer Bio (GOSS) over the last 2 years, with Q3 2025 value amounting to $27.1 million.

  • Gossamer Bio's Non-Current Deffered Revenue fell 3812.79% to $27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.1 million, marking a year-over-year decrease of 3812.79%. This contributed to the annual value of $38.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Gossamer Bio reported Non-Current Deffered Revenue of $27.1 million as of Q3 2025, which was down 3812.79% from $31.5 million recorded in Q2 2025.
  • Gossamer Bio's Non-Current Deffered Revenue's 5-year high stood at $49.7 million during Q2 2024, with a 5-year trough of $27.1 million in Q3 2025.